Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) were trading higher by nearly 9 percent early Monday morning. Acadia Pharmaceuticals announced after Friday s market close that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration will review data. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: